Fig. 1From: Altered cfDNA fragmentation profile in hypomethylated regions as diagnostic markers in breast cancerSchematic representation of the improved cfMeDIP-seq approach. Plasma was collected from patients with breast cancer and healthy individuals. cfDNA was extracted and processed with adapter ligation and 5mC-immunoprecipitation (IP) for sequencing library construction. cfDNA methylation and fragmentation profile were identified through analyzing the NGS dataBack to article page